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ABSTRACT
Background: Myocardial apoptosis plays an important role in myocardial
ischemia/reperfusion (I/R) injury. Activation of PI3K/Akt signaling protects the
myocardium from I/R injury. This study investigated the role of miR-214 in hypoxia/
reoxygenation (H/R)-induced cell damage in vitro and myocardial I/R injury in vivo.
Methods and Results: H9C2 cardiomyoblasts were transfected with lentivirus
expressing miR-214 (LmiR-214) or lentivirus expressing scrambled miR-control
(LmiR-control) respectively, to establish cell lines of LmiR-214 and LmiR-control.
The cells were subjected to hypoxia for 4 h followed by reoxygenation for 24 h.
Transfection of LmiR-214 suppresses PTEN expression, significantly increases the
levels of Akt phosphorylation, markedly attenuates LDH release, and enhances the
viability of the cells subjected to H/R. In vivo transfection of mouse hearts with
LmiR-214 significantly attenuates I/R induced cardiac dysfunction and reduces I/Rinduced myocardial infarct size. LmiR-214 transfection significantly attenuates I/Rinduced myocardial apoptosis and caspase-3/7 and caspase-8 activity. Increased
expression of miR-214 by transfection of LmiR-214 suppresses PTEN expression,
increases the levels of phosphorylated Akt, represses Bim1 expression and induces
Bad phosphorylation in the myocardium. In addition, in vitro data shows transfection
of miR-214 mimics to H9C2 cells suppresses the expression and translocation of Bim1
from cytosol to mitochondria and induces Bad phosphorylation.
Conclusions: Our in vitro and in vivo data suggests that miR-214 protects
cells from H/R induced damage and attenuates I/R induced myocardial injury. The
mechanisms involve activation of PI3K/Akt signaling by targeting PTEN expression,
induction of Bad phosphorylation, and suppression of Bim1 expression, resulting in
decreases in I/R-induced myocardial apoptosis.

miRs, such as miR-1/106, miR-125b, miR-146a, miR-223,
miR-21, miR-144/145, miR-320, miR-494, and miR-92a,
are involved in ischemic heart disease [1–8]. miR-214
has been reported to protect cardiac myocytes from H2O2induced injury [9]. Recently, Aurora et al [10] have shown
that deficiency of miR-214 resulted in severe myocardial
ischemia/reperfusion (I/R) injury and increased fibrosis

INTRODUCTION
MicroRNAs (miRs) are 21 to 23 nucleotide
non-protein-coding RNA molecules, which have been
identified as novel regulators of gene expression at the
post-transcriptional level by binding to target messenger
RNAs (mRNAs). Recently published data indicates that
www.impactjournals.com/oncotarget
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progression as well as cardiac myocyte apoptosis. These
authors demonstrated that miR-214 targets sodiumcalcium exchanger-1, thus influencing cardiac myocyte
calcium trafficking following myocardial I/R injury [10].
It is well known that myocardial apoptosis
contributes to myocardial I/R injury [11]. Bad is a proapoptotic protein, a member of the Bcl-2 family and
induces apoptosis by inhibiting the anti-apoptotic effects
of Bcl-2 and Bcl-X, thereby allowing the pro-apoptotic
proteins, Bak and Bax to aggregate and induce release of
cytochrome c, followed by activation of caspase-mediated
apoptotic signaling [12]. Phosphorylation of Bad by
activated Akt prevents the interaction of Bad with Bcl-2
and Bcl-X [13]. Bcl-2 homology domain 3 (BH3)-only
Pro-Protein Bim1 is an another pro-apoptotic protein and
plays an important role in Bax/Bak mediated cytochrome c
release and apoptosis [14]. Bim expression is regulated by
activated FOXO3 (Forkhead box transcription factor, class
O) which is controlled by activated phosphatidylinositol
3-kinase (PI3K)/Akt signaling [15]. In addition, activated
Akt phosphorylates Bim1 at Ser87, resulting in blocking
the pro-apoptotic effect of Bim1 [16].
Toll like receptor (TLR)-mediated innate immune and
inflammatory responses have been demonstrated to play a
critical role in myocardial ischemia/reperfusion (I/R) injury
[17]. We have previously reported that administration of
TLR ligands to mice induced protection against myocardial
I/R injury [18–20]. The protective mechanisms involve
the activation of PI3K/Akt signaling [18–21] which plays
an important role in regulating cellular proliferation and
survival [22, 23]. Phosphatase and tensin homolog (PTEN)
is a tumor suppressor lipid protein phosphatase which
negatively regulates PI3K/Akt signaling activation [24] by
dephosphorylating PIP3 at its 3’ inositol position, resulting
in decreased translocation of Akt to cellular membranes and
subsequent down-regulation of PI3K/Akt activation [25].
Recent studies have shown PTEN plays a critical role in
mitochondrial dependent apoptosis [26].
In the present study, we demonstrated that increased
expression of miR-214 by transfection of the myocardium
with lentivirus expressing miR-214 (LmiR-214)
protects hearts from I/R injury. The mechanisms involve
suppression of PTEN expression, leading to activation of
PI3K/Akt signaling, induction of Bad phosphorylation,
and targeting Bim1 expression, resulting in attenuation of
I/R-induced myocardial apoptosis.

PI3K/Akt dependent mechanism [20]. Interestingly,
we observed that the levels of myocardial miR-214
were markedly greater in either TLR4 deficient mice
or Pam3CSK4 treated mice compared with untreated
group (Figure 1A). Our previous studies have shown that
TLR2 modulation can significantly attenuate I/R induced
myocardium injury by activating PI3K/Akt signaling.
PTEN, a negative regulator of PI3K/Akt signaling is a
potential target of miR-214. To investigate the underlying
mechanisms by which TLR2 modulation regulates the
miR-214 expression, H9C2 cardiomyoblasts were treated
with TLR2 specific ligand Pam3CSK4. As shown in Figure
1B, the levels of miR-214 in Pam3CSK4 treated cells are
significantly increased. The levels of phosphorylated Akt are
also significantly increased following Pam3CSK4 treatment
(Figure 1C) which is consistent with our previous studies.
However, PI3K inhibition with LY294002 (LY) significantly
prevented Pam3CSK4 induced Akt phosphorylation but
did not alter Pam3CSK4 induced increases in miR-214
expression. To determine whether NF-kB signaling involves
Pam3CSK4 induced miR-214 expression, we treated cells
with NF-kB specific inhibitor, JSH-23 and observed that
JSH-23 treatment significantly prevented Pam3CSK4
induced increases in the expression of miR-214 (Figure 1B).
Collectively, these data suggest the TLR2 ligand induced
increases in the expression of miR-214 are mediated through
NF-kB activation pathway.
To examine whether increased expression of miR214 will activate PI3K/Akt signaling, we transfected H9C2
cells with lentivirus expressing miR-214 (LmiR-214) or
LmiR-control respectively, before the cells were subjected
to hypoxia (4 h) followed by reoxygenation (H/R). Figures
1D and 1E show that LmiR-214 transfection markedly
increases the levels of Akt phosphorylation and suppresses
PTEN expression in the presence or absence of H/R. The
data suggests that miR-214 targets PTEN expression,
resulting in activation of PI3K/Akt signaling.

Increased expression of miR-214 attenuates H/R
induced cell injury and increases survival in
H9C2 cardiomyoblasts
Activation of PI3K/Akt signaling plays an important
role in protection against H/R-induced cell injury [27, 28].
We examined whether transfection of LmiR-214 will protect
the H9C2 cells from H/R-induced injury. Figure 1F shows
that H/R significantly increased LDH activity by 5.6-fold
compared with the control cells (normoxia). In contrast,
transfection of cells with LmiR-214 markedly attenuates
H/R-induced LDH activity by 54%, when compared with
untransfected H/R group. H/R also significantly decreased
cell viability by 47% compared with normoxia group (Figure
1G). However, the viability in LmiR-214 transfected cells
that were subjected to H/R was significantly greater by 75%
compared with H/R group. Transfection of LmiR-control did
not affect H/R-induced cell injury and death in H9C2 cells.

RESULTS
Increased miR-214 levels suppressed PTEN
expression and increased Akt phosphorylation in
H9C2 cardiomyoblasts
We have previously reported that either TLR4
deficiency or TLR2 modulation by Pam3CSK4 significantly
attenuates-I/R induced myocardial injury via activating
www.impactjournals.com/oncotarget
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Figure 1: A. TLR4 deficiency or TLR2 ligand, Pam3CSK4 treatment increases the expression of miR-214 in the myocardium. TLR4
deficient (TLR4-/-) mice (n=3) or wild type (WT) mice were treated with and without Pam3CSK4 (50 µg/25 g body weight) and then
subjected to myocardial ischemia (45 min) followed by reperfusion (4 h). Sham surgical operation served as sham control. Hearts were
harvested and microRNAs were isolated for qPCR measurement of miR-214 (n=3-4/group). B-C. NF-kB activation is required for
Pam3CSK4 induced miR-214 expression. Myoblast H9C2 cells were treated with PamsCSK4 in the presence of LY294002 or JSH23 for
24 hrs. The cells were harvested for qPCR measurement of miR-214 expression (B) and for Western blot analysis of Akt phosphorylation
(C). There were 3 replicates in each group. * p<0.05 compared with indicated groups. D-G. H9C2 cells were transfected with lentivirus
expressing miR-214 (LmiR-214) or lentivirus expressing miR-control (LmiR-control) respectively. The cells were subjected to hypoxia (4
h) followed by reoxygenation (24 h). The levels of Akt phosphorylation (D) and PTEN expression (E) were assessed by Western blot (n=3).
LDH activity (F) in the supernatants was measured by a commercially available kit and cell viability (G) was measured by MTT assay
(n=3-5). *p<0.05 compared with indicated groups. # p<0.05 compared with respective control.
www.impactjournals.com/oncotarget

86928

Oncotarget

LmiR-214 transfection attenuates cardiac
dysfunction and reduces infarct size after
myocardial I/R

whether in vivo transfection of LmiR-214 will protect
the heart from myocardial I/R injury. Mouse hearts were
transfected with LmiR-214 through the right carotid artery
[1, 2]. LmiR-control served as vector control. Figure 2D
shows that seven days after transfection, the levels of miR214 in the myocardium were significantly increased by
3.7-fold compared with control. We also examined whether

Our in vitro data shows that increased expression
of miR-214 markedly activates PI3K/Akt signaling and
protects H9C2 cells from H/R-induced injury. We evaluated

Figure 2: Transfection of lentivirus expressing miR-214 into the myocardium improves cardiac function and decreases
infarct size following myocardial I/R injury. Mouse hearts were transfected with LmiR-214 through the right common carotid artery
(n=8/group). Seven days after transfection, hearts were subjected to ischemia (45 min) followed by reperfusion for up to 7 days. A and B.
Cardiac function was measured by echocardiography 3 and 7 days after myocardial I/R. C. Hearts were harvested 24 h after reperfusion for
TTC staining infarct size. D. The level of miR-214 was increased following LmiR-214 transfection. E. LmiR-214 transfection suppresses
PTEN expression and increases Akt phosphorylation levels. n=6/group. * P<0.05 compared with indicated group. # p<0.05 compared with
respective control.
www.impactjournals.com/oncotarget
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increased expression of miR-214 will protect against
myocardial I/R-induced injury. The hearts were subjected
to ischemia (45 min) followed by reperfusion up to 7 days.
As shown in Figures 2A and 2B, I/R significantly decreased
cardiac function. The values for ejection fraction (EF%)
and fractional shortening (FS%) were markedly reduced by
38.1% and 44.5% on day 3 and by 24.6% and 32.1% on day
7 respectively, after myocardial I/R injury compared with
sham control. In contrast, LmiR-214 transfection attenuated
I/R-induced cardiac dysfunction. The values for EF% and
FS% in LmiR-214 transfected hearts were significantly
greater than in the untransfected I/R group. Figure 2C
shows that transfection of LmiR-214 into the hearts
markedly reduced infarct size by 52.1% compared with the
untransfected I/R group. Transfection of LmiR-control into
the myocardium did not alter I/R-induced decreases in the
values of EF% and FS% and myocardial infarct size.

myocardial caspase-3/7 and caspase-8 activities (Figures
3B and 3C). Transfection of LmiR-control did not alter I/Rinduced myocardial apoptosis.

LmiR-214 transfection increases Bad
phosphorylation and suppresses the expression
of Bim1 in the myocardium
Bad is a pro-apoptotic protein which interacts with
Bcl2, resulting in blocking Bcl2 anti-apoptotic function
[34]. When Bad is phosphorylated, Bcl2 will release from
Bad/Bcl2 complex and functions in an anti-apoptotic role
[13, 34, 35]. Figure 4A shows that transfection of LmiR-214
markedly increases the levels of phosphorylated Bad in both
sham and I/R groups compared with untransfected respective
controls. Bim1 is a mitochondrial pro-apoptotic factor which
will translocate from the cytosol to mitochondria, resulting
in cardiomyocyte apoptosis during I/R [14, 36]. As shown
in Figure 4B, I/R decreased the cytosolic levels of Bim1
compared with sham control. However, transfection of
LmiR-214 further decreases the cytosolic levels of Bim1 in
both sham and I/R groups, indicating increased expression
of miR-214 may suppress the expression and translocation
of Bim1 from cytosol to mitochondria. Transfection of
LmiR-control did not alter I/R induced changes of Bad
phosphorylation and Bim1 expression.

LmiR-214 transfection suppresses PTEN
expression and increases Akt phosphorylation in
the myocardium
PTEN is a negative regulator of PI3K/Akt signaling
[29, 30]. We examined the effect of LmiR-214 transfection
on PTEN expression and Akt phosphorylation in the
myocardium following I/R. Figure 2E shows that I/R
did not affect PTEN expression but enhanced the levels
of Akt phosphorylation compared with sham control.
However, LmiR-214 transfection significantly suppresses
the expression of PTEN and further increases Akt
phosphorylation levels in both sham and I/R groups when
compared with untransfected respective controls. In the
LmiR-214 transfected group, the levels of phosphorylated
Akt were increased by 34.1% and PTEN decreased by
42.4%, when compared with untransfected I/R hearts.
Transfection of LmiR-control did not alter the levels
of Akt phosphorylation and PTEN expression in the
myocardium of both sham and I/R groups.

LmiR-214 suppresses the translocation of Bim1
from cytosol to mitochondria in cardiomyoblasts
following H/R
To examine the effect of miR-214 on Bim1
translocation from cytosol to mitochondria, we transfected
H9C2 cells with miR-214 mimics or scrambled miR-control
respectively, before the cells were subjected to hypoxia/
reoxygenation (H/R). Figures 5A and 5B show that H/R
induces translocation of Bim1 from the cytosol to the
mitochondria as evidenced by a significant decrease in the
cytosolic levels of Bim1 (A), but a markedly enhanced
amount of Bim1 in mitochondrial extracts (B). In contrast,
miR-214 markedly suppresses the expression of Bim1 in the
cytosol and decreases the levels of Bim1 in the mitochondria
following H/R challenge. MiR-214 transfection also
significantly increases Bad phosphorylation in the presence
and absence of H/R compared with untransfected control
groups (Figure 5C). Transfection of scrambled miR-control
did not induce Bad phosphorylation in the presence and
absence of H/R. In addition, H/R markedly decreased
mitochondrial membrane potential which was significantly
attenuated by LmiR-214 transfection (Figure 5D).

Increased expression of miR-214 attenuates I/R
induced myocardial apoptosis
It is well known that myocardial apoptosis contributes
to cardiac dysfunction after myocardial I/R injury [31]. We
examined the effect of LmiR-214 transfection on myocardial
apoptosis following myocardial I/R injury. Figure 3A shows
that I/R increased Tunnel positive myocardial apoptotic
cells by 29.8% compared with sham control. In contrast,
transfection of LmiR-214 into the myocardium significantly
decreases I/R-induced myocardial apoptosis by 60.9%, when
compared with the untransfected I/R group. Activation of
caspase-3/7 and caspase-8 have been considered as specific
markers for apoptosis [32, 33]. Figures 3B and 3C show that
I/R-induced an increase in capase-7 by 30% and caspase-8
by 40.4%, when compared with sham control. However,
increased expression of miR-214 prevents I/R-induced
www.impactjournals.com/oncotarget

DISCUSSION
In the present study, we demonstrated that increased
expression of miR-214 in the myocardium significantly
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Figure 3: Increased expression of miR-214 attenuates I/R-induced myocardial apoptosis. LmiR-214 or LmiR-control was

transfected into the myocardium of mice via the right common carotid artery 7 days before the hearts were subjected to ischemia (45 min)
followed by reperfusion (24 h). Hearts were harvested and sectioned for TUNEL assay of myocardial apoptosis A. Caspase-3/7 B. and
Caspase-8 C. activities were measured by ELISA kits. N=4-6, *p<0.05 compared with indicated group.

Figure 4: Increased expression of miR-214 suppresses Bim expression and increases Bad phosphorylation in the
myocardium following myocardial I/R. LmiR-214 or LmiR-control was transfected into the myocardium of mice via the right
common carotid artery 7 days before the hearts were subjected to ischemia (45 min) followed by reperfusion (24 h). The hearts were
harvested for isolation of cellular proteins. The levels of phosphorylated Bad A. and Bim1 B. were examined by Western blot. N=4-6,
*p<0.05 compared with indicated group.
www.impactjournals.com/oncotarget
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attenuates I/R-induced cardiac dysfunction and myocardial
infarct size. The mechanisms involve an anti-apoptotic
effect via activation of PI3K/Akt signaling and suppression
of Bim expression. Specifically, we observed that miR214 suppresses PTEN expression, leading to activation
of PI3K/Akt signaling. It is well known that activated

Akt phosphorylates Bad [13], thereby blocking the proapoptotic effect of Bad. In addition, miR-214 represses
the expression of pro-apoptotic protein Bim1 [10] and
its translocation from cytosol to the mitochondria, thus
preventing I/R induced apoptosis.

Figure 5: Increased expression of miR-214 suppresses the expression and mitochondrial translocation of Bim1 and
increases the levels of phosphorylated Bad in cardiomyoblasts H9C2 cells. H9C2 cells were transfected with miR-214 mimics.
miR-control mimics served as control. The cells were subjected to hypoxia (4 h) followed by reoxygenation (24 h). The cells were harvested for
isolation of mitochondria. The levels of Bim1 A and B. and phosphorylated Bad C. were examined by Western blot. n=3/group. D. Mitochondrial
membrane potential was measured by JC-1 Dye (n=6-8). * p<0.05 compared with indicated groups. # p<0.05 compared with respective control.
www.impactjournals.com/oncotarget
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We have previously reported that there is an
interaction between TLR-mediated pathway and PI3K/Akt
signaling during myocardial I/R injury [20, 37]. Activation
of PI3K/Akt signaling has been reported to protect the
myocardium from I/R injury and promotes cell survival
following H/R [27, 28, 37, 38]. However, the mechanisms
by which stimulation of TLRs induces activation of PI3K/
Akt signaling are unclear. Interestingly, we observed that
miR-214 expression in the myocardium was significantly
increased by a TLR2 ligand, Pam3CSK4, in the presence
and absence of I/R. Since Pam3CSK4 induced activation
of PI3K/Akt signaling [20], we examined whether
increased miR-214 expression would activate PI3K/Akt
signaling. Indeed, our data show that increased expression
of miR-214 by transfection of LmiR-214 into H9C2 cells
suppresses PTEN expression and increases the levels of
Akt phosphorylation in the presence and absence of H/R
challenge. LmiR-214 transfection also markedly attenuates
H/R-induced cell injury as evidenced by decreased LDH
release after the cells were subjected to H/R. In addition, cell
viability was markedly improved by increased expression of
miR-214. Collectively, the in vitro data suggests that miR214 has a protective effect on H/R-induced cell injury via
suppression of PTEN, leading to activation of PI3K/Akt
signaling.
Next, we investigated whether increased
expression of miR-214 in the myocardium would protect
the hearts from I/R-induced injury. We constructed
LmiR-214 and transfected it into the myocardium
through the right carotid artery seven days before the
hearts were subjected to myocardial I/R [1, 2]. The in
vivo data shows that LmiR-214 transfection prevents
I/R-induced cardiac dysfunction and reduced I/Rinduced myocardial infarct size. Our data is consistent
with the report by Aurora et al [10] showing that
deficiency of miR-214 resulted in more severe cardiac
dysfunction and myocardial I/R injury, indicating that
miR-214 is essential for cardioprotection against I/R
injury. To understand the mechanisms by which miR214 protects against myocardial I/R injury, Aurora et
al [10] observed that miR-214 targets sodium-calcium
exchanger-1, thereby influencing calcium trafficking
in cardiac myocytes after myocardial I/R injury [10].
We found that miR-214 significantly suppresses PTEN
expression, leading to Akt phosphorylation in the
myocardium. Previous studies have demonstrated that
activation of PI3K/Akt signaling plays a critical role in
reduced I/R-induced injury and attenuated I/R-induced
cardiac dysfunction [18–21]. Our data indicates that
activation of PI3K/Akt signaling by miR-214 may be an
important mechanism for protection against I/R injury.
We observed that increased expression of miR-214
significantly attenuates I/R-induced myocardial apoptosis.
Apoptosis has been demonstrated to contribute to I/Rinduced myocardial damage and cardiac dysfunction [31].
Apoptosis is the process of programmed cell death which
is predominately dependent on mitochondrial function
www.impactjournals.com/oncotarget

[39]. Bcl2 family members play a critical role in regulating
mitochondrial mediated apoptosis through controlling the
permeabilization of the mitochondrial membrane [39].
Bad is a pro-apoptotic protein that promotes activation
of the programmed cell death pathway through formation
of heterodimerizes with Bcl2 or Bcl-XL to inhibit their
anti-apoptotic functions [35]. Our in vitro and in vivo data
show that increased miR-214 expression significantly
enhances Bad phosphorylation, thereby blocking Bad’s
pro-apoptotic effect. It has been reported that Bad is
phosphorylated by a variety of kinases including Akt and
P70S60 kinase [13, 34] with subsequent loss of its proapoptotic action by binding with 14-3-3 protein [35, 40].
Our findings indicate that targeting PTEN expression by
mir-214, resulting in activation of Akt could be responsible
for Bad phosphorylation.
We also found that increased expression of miR214 represses the expression of Bim1 and prevents its
translocation from the cytosol to mitochondria. Bim1 is
another pro-apoptotic protein of Bcl-2 family and triggers
apoptosis by inhibiting Bcl2 anti-apoptotic function and/
or direct activation of Bax [14], leading to cytochrome
c release and activation of apoptotic signaling [39].
Therefore, suppression of Bim1 expression and preventing
its translocation from the cytosol to the mitochondria are
necessary for preventing apoptosis during myocardial I/R
injury [36]. Aurora et al reported that the expression of Bim1
in the myocardium was significantly increased in miR-214
deficient mice 7 days after myocardial I/R injury, indicating
that miR-214 may target Bim [10]. We demonstrated in the
present study that increased in vivo expression of miR-214
by LmiR-214 transfection suppresses the expression of Bim1
in the myocardium following I/R injury and that in vitro
enhanced miR-214 levels prevent the translocation of Bim1
from the cytosol to the mitochondria. Collectively, targeting
Bim1 expression and preventing its translocation from
cytosol to mitochondria could be an important protective
mechanism of miR-214 in myocardial I/R injury.
In summary, our data demonstrated that miR-214
plays a protective role in myocardial I/R injury. The
mechanisms involve an anti-apoptotic effect through
suppression of PTEN expression, leading to activation
of PI3K/Akt signaling which suppresses Bad activity via
its phosphorylation. In addition, miR-214 suppresses the
expression and translocation of Bim1 from the cytosol
to the mitochondria. MiR-214 could be a target for the
induction of protection against myocardial I/R injury.
Future studies should search for which natural conditions
will induce miR-214 expression.

MATERIALS AND METHODS
Animals
Male C57BL/6J mice were obtained from Jackson
Laboratory and maintained in the Division of Laboratory
Animal Resources, East Tennessee State University
86933
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(ETSU). The experiments outlined in this article conform
to the Guide for the Care and Use of Laboratory Animals
published by the National Institutes of Health (NIH
Publication, 8th Edition, 2011). All aspects of the animal
care and experimental protocols were approved by the
ETSU Committee on Animal Care.

accordance with the manufacturer’s protocol. Quantitative
real-time (qPCR) was conducted using a 4800 Real-time
PCR machine (Bio-Rad). MicroRNA levels were quantified
by qPCR using specific Taqman assays for miR (Applied
Biosystems, USA) and Taqman Universal Master Mix
(Applied Biosystems). Specific primers for miR-214 were
obtained from Applied Biosystems. MicroRNA-214 levels
were quantified with the 2 (-DDct) relative quantification
method that was normalized to the snRU6.

Induction of myocardial I/R injury
Myocardial I/R injury was induced as described
previously [1, 2, 18, 20, 21]. Briefly, the mice were
anesthetized by 5.0% isoflurane, intubated and ventilated
using a rodent ventilator. Anesthesia was maintained
by inhalation of 1.5% to 2% isoflurane driven by 100%
oxygen flow. Body temperature was regulated at 37oC
by surface water heating. The hearts were exposed and
the left anterior descending (LAD) coronary artery was
ligated with an 8-0 silk ligature. After completion of 45
min of occlusion, the coronary artery was reperfused by
releasing the suture knot. After reperfusion for the time
indicated, the mice were euthanized by CO2 inhalation
and the hearts were harvested. Infarct size was evaluated
by triphenyltetrazolium chloride (TTC, Sigma-Aldrich)
staining as described previously [1, 2, 18, 20, 21].

Construction of lentivirus expressing miR-214
MiR-214 was constructed into a lentivirus
expressing vector using a lentivirus expressing system
(Invitrogen Corporation) as described previously [1, 2].
Briefly, the oligonucleotides for miR-214 were synthesized
at Integrated DNA Technologies, annealed and ligated into
pcDNATM6.2-GW/EmGFP-miR. The pcDNATM6.2GW/EmGFP-miR cassette was subsequently transferred
to pDONR221TM and finally pLenti6/V5-DEST by two
sequential Gateway BP and LR recombinations. The
construct was verified by sequencing. The viral particles
were produced by third generation packaging in 293FT
cells and lentiviral stocks were concentrated using
ultracentrifugation.

Echocardiography

Transfection of lentivirus expressing miRNA

Transthoracic
two-dimensional
M-mode
echocardiogram and pulsed wave Doppler spectral
tracings were obtained using a Toshiba Aplio 80 Imaging
System (Tochigi, Japan) equipped with a 12-MHz linear
transducer as described previously [1, 2, 19, 20]. Ejection
fraction (EF) and percent fractional shortening (FS) were
calculated as described previously [1, 2, 19, 20].

We transfected mouse hearts with lentivirus
expressing miR-214 (LmiR-214) or lentivirus expressing
miR-control (LmiR-control) via the right common carotid
artery as described previously [1, 2]. Briefly, mice were
intubated and anesthetized with mechanical ventilation
using 5% isoflurane. The anesthesia was maintained by
inhalation of 1.5-2% isoflurane in 100% oxygen. An
incision was made in the middle of the neck and the
right common carotid artery was carefully isolated. A
micro-catheter was introduced into the isolated common
carotid artery and positioned into the aortic root through
an arteriotomy site in the external carotid artery [1, 2].
One hundred microliters of LmiR-214 (1x107 PFU) or
LmiR-Con was injected through the micro-catheter. The
micro-catheter was gently removed and the common
carotid artery was tightened before the skin was closed.
Seven days after transfection, the hearts were harvested
and transfection efficiency was evaluated by examining
the green fluorescent protein (GFP) expression and the
expression of miR-214 in the heart tissues.

In situ apoptosis assay
Measurement of cardiac myocyte apoptosis was
performed as described previously [1, 2, 18–21] using the
in situ cell death detection kit, fluorescein (Roche, USA)
according to instructions of the manufacturer.

Measurement of cell viability and mitochondrial
membrane potential
Cell viability was assessed by measuring
mitochondrial dehydrogenase activity using the
MTT assay kit (Sigma). Cell injury was assessed by
measurement of lactate dehydrogenase (LDH) activity
in culture medium using a commercial kit (Cytotoxicity
Detection Kit, Sigma). Mitochondrial membrane potential
was evaluated by the fluorescence ratio of JC-1 aggregates
(red) to monomers (green).

In vitro experiments
The H9C2 cardiomyoblasts stably expressing miR214 or miR-con were generated by transfection of LmiR214 or LmiR-con and selection with Blasticidin (Invitrogen).
Transient expression of miR-214 in H9C2 cells was
accomplished by transfection of miR-214 mimics (40 nM)
or miR-control mimics (40 nM). The cells were subjected

Real time PCR assay of miRNAs
miRs were isolated from heart tissues or cultured cells
using the miRNAs isolation kit (RNAzol®RT, MRC) in
www.impactjournals.com/oncotarget
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to hypoxia/reoxygenation as described previously1. Briefly,
the medium was changed to hypoxia-equilibrated medium
immediately before the cells were incubated at 37°C with
5% CO2 and 0.1% O2 in a hypoxia chamber (Pro-Ox Model
C21, BioSpherix Ltd, Redfield NY) for 4 h followed by
reoxygenation in an incubator with 5% CO2. The cells that
were not subjected to H/R served as control (normoxia). The
cells were harvested and cellular proteins were isolated for
Western blot analysis [19–21].

p53-mediated apoptotic signalling and TRAF6. Cardiovasc
Res 2014; 102:385-395.
2. Wang X, Ha T, Liu L, Zou J, Zhang X, Kalbfleisch J, Gao
X, Williams D, Li C. Increased expression of microRNA146a decreases myocardial ischemia/reperfusion injury.
Cardiovascular Research 2013; 97:432-442.
3. Cheng Y, Zhu P, Yang J, Liu X, Dong S, Wang X, Chun B,
Zhuang J, Zhang C. Ischaemic preconditioning-regulated
miR-21 protects heart against ischaemia/reperfusion injury
via anti-apoptosis through its target PDCD4. Cardiovasc
Res 2010; 87:431-439.

Mitochondrial isolation and Western blot

4. Ren XP, Wu J, Wang X, Sartor MA, Qian J, Jones K,
Nicolaou P, Pritchard TJ, Fan GC. MicroRNA-320 is
involved in the regulation of cardiac ischemia/reperfusion
injury by targeting heat-shock protein 20. Circulation 2009;
119:2357-2366.

Mitochondria were isolated from H9C2 cells
using a mitochondrial isolation kit (Thermo Scientific)
according to the manufacturer’s protocol. Western blots
were performed as described previously [19–21]. The
membranes were incubated with appropriate primary
antibodies respectively, including anti-PTEN, anti-p-Akt,
anti-Akt, anti-Bim, anti-p-Bad, anti-Bad (Cell Signaling
Technology, Inc, Danvers, MA), respectively, followed by
incubation with peroxidase-conjugated second antibodies
(Cell Signaling Technology, Inc.) and examination with
the ECL system (Amersham Pharmacia, Piscataway, NJ).
The signals were quantified using a G: Box gel imaging
system by Syngene (Syngene, USA, Frederick, MD).

5. Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi
M, Fischer A, Burchfield J, Fox H, Doebele C, Ohtani K,
Chavakis E, Potente M, Tjwa M, Urbich C, Zeiher AM,
Dimmeler S. MicroRNA-92a Controls Angiogenesis and
Functional Recovery of Ischemic Tissues in Mice. Science
2009; 324:1710-1713.
6. Wang X, Zhang X, Ren XP, Chen J, Liu H, Yang J,
Medvedovic M, Hu Z, Fan GC. MicroRNA-494 targeting
both proapoptotic and antiapoptotic proteins protects against
ischemia/reperfusion-induced cardial injury. Circulation
2010; 122:1308-1318.

Caspase-3/7 and caspase-8 activities assay
Caspase-3/7 and caspase-8 activity were measured
using a Caspase-Glo assay kit (Promega) according to the
manufacturer’s protocol as described previously [20].

7. Zhang X, Wang X, Zhu H, Zhu C, Wang Y, Pu WT, Jegga
AG, Fan G-C. Synergistic effects of the GATA-4-mediated
miR-144/451 cluster in protection against simulated
ischemia/reperfusion-induced cardiomyocyte death. J Mol
Cell Cardiol 2010; 49:841-850.

Statistical analysis

8. Qin D, Wang X, Li Y, Yang L, Wang R, Peng J, Essandoh K,
Mu X, Peng T, Han Q, Yu KJ, Fan GC. MicroRNA-223-5p
and -3p Cooperatively Suppress Necroptosis in Ischemic/
Reperfused Hearts. J Biol Chem 2016; 291:20247-20259.

Data are expressed as mean ± SD. Comparisons of
data between groups were made using one-way analysis
of variance (ANOVA), and Tukey’s procedure for
multiple-range tests was performed. The overall survival
probabilities were analyzed using the log-rank test. P<
0.05 was considered to be significant.

9. Lv G, Shao S, Dong H, Bian X, Yang X, Dong S.
MicroRNA-214 protects cardiac myocytes against H2O2
-induced injury. J Cell Biochem 2014; 115:93-101.
10. Aurora AB, Mahmoud AI, Luo X, Johnson BA, van Rooij E,
Matsuzaki S, Humphries KM, Hill JA, Bassel-Duby R, Sadek
HA, Olson EN. MicroRNA-214 protects the mouse heart from
ischemic injury by controlling Ca2+ overload and cell death.
The Journal of Clinical Investigation 2012; 122:1222-1232.
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